What Makes Us Different And Better

Our solution integrates an innovative technology that is patented to ensure its uniqueness. In addition, it has been validated by a clinical trial with 100 patients, and incorporates a regulatory approach in order to differentiate from a simple electronic gadget, and a big-data value (valuable information for industry and doctors). Moreover, our solution can be easily adapted to other conditions than anaphylaxis.

PATENT NUMº US 2018 / 0061208 A1

Our Story

Adan Medical Innovation was born in July 2013 between Silicon Valley and Barcelona. The idea became a reality during an Innovation program (Imagine Creativity Center) in Silicon Valley, were the co-founders Anna Sala and Adrian Curran reframed all the concerns that the patients who suffer allergic reactions have and prototyped the idea, defining the next steps. The first thing was to put together an appropriate team, with the main aim of “improving the quality of life of patients that suffer anaphylaxis”.

“If you want to go fast go alone, but if you want to go far go together “. With this in mind, Adan Medical Innovation wanted to be a different health tech company, and created a multidisciplinary team with experts in all the different areas that the project needed (clinical, regulatory, hardware&software, quality control, design…), also including patients, to be able to bring excellence to the project.

During these years, the team has grown and worked very hard, always with the purpose to improve the development of our solution. The first clinical trial with a device evaluating its usefulness for the management of anaphylaxis has been completed in one of the largest hospitals in Europe. Currently, with the improved solution and the clinical trial completed, we are working on the last steps to bring anAPPhylaxis to the market, which involve regulatory clearance. In addition, we are also working with new technologies to bring our solution to public spaces using IOT, to be able to improve the quality of life of all potential patients and increase the awareness and knowledge of the disease around the world.


Our mission is to improve the quality of life of patients that suffer severe allergic reactions requiring epinephrine. To achieve this we have formed a group of experts in different fields (physicians specialized in Allergy and Internal Medicine, business development, patent and regulatory health technologies issues, engineers, information technologies), even including patients amongst us, and we are working together to offer the best solutions for these patients.


Entrepreneur with extensive knowledge in the Health Sector, specifically in Automatic Defibrilators. Highly experienced in the PYME world, has created and directed several companies.


PhD. Chairman

Industry specialist, he has led the discovery and development of new treatments in the biopharmaceutical industry in USA, with three drugs approved and two Phase III, plus two medical devices marketed.

M.D, PhD, Co-Founder
& Medical Director

Allergy specialist in Vall d’Hebron Hospital. Associate Prof. of Inmunology. Member of the World Allergy Organization and the European Academy of Allergy and Clinical Immunology and different Cientific Committee with more than 35 indexed international papers.


Electronics engineer with more than 10 years of experience in design, development and technical coordination of research and innovation projects.

M.D, PhD. Co-Founder
& Medical Advisor

Internal Medicine specialist in Vall d’Hebron Hospital. acts as an advisor for different pharmaceutical companies and has more than 70 indexed international papers.

COO, Chief Operating Officer

Product Engineer MBA with more than 20 years in product development, testing and industrialization.